Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$30.6B
sum of reported positions
Reported positions
278
Changes vs prior quarter
285
69 new · 41 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 523 measured positions in 8 quarters, the typical new or larger position finished −4.6 pts against the S&P 500 and 40% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 8.08M | $1.62B | 5.3% | |
| 3.75M | $1.34B | 4.4% | |
| 4.8M | $1.28B | 4.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $30.6B |
| Positions | 250 | 278 |
| Biggest line | — | NVIDIA 5% |
| 1.49M |
| $836M |
| 2.7% |
| 2.94M | $795M | 2.6% |
| 2.57M | $745M | 2.4% |
| 355K | $704M | 2.3% |
| 1.56M | $588M | 1.9% |
| 1.41M | $528M | 1.7% |
| 1.92M | $517M | 1.7% |
| 417K | $500M | 1.6% |
| 1.74M | $442M | 1.4% |
| 929K | $413M | 1.3% |
| 677K | $382M | 1.2% |
| 1.05M | $353M | 1.2% |
| 241K | $283M | 0.9% |
| 228K | $263M | 0.9% |
| 762K | $262M | 0.9% |
| 6.15M | $261M | 0.9% |
| 1.7M | $248M | 0.8% |
| 2.21M | $245M | 0.8% |
| 6M | $245M | 0.8% |
| 511K | $244M | 0.8% |
| 1.62M | $244M | 0.8% |
| 331K | $239M | 0.8% |
Saia (SAIA)
156K → 154K shares (−1%)
NXP Semiconductors (NXPI)
248K → 227K shares (−8%)
Sensata Technologies (ST)
1.33M shares
HealthEquity (HQY)
713K → 703K shares (−1%)
BrightSpring Health Services (BTSG)
898K shares
Relay Therapeutics (RLAY)
3.34M shares
Houlihan Lokey (HLI)
544K → 463K shares (−15%)
Entegris (ENTG)
372K → 345K shares (−7%)
Core Scientific, Inc. (CORZ)
1.48M → 2.41M shares (+63%)
RadNet, Inc. (RDNT)
532K → 976K shares (+83%)
Oruka Therapeutics (ORKA)
313K → 631K shares (+102%)
Credo Technology Group Holding (CRDO)
926K → 217K shares (−77%)
Builders Firstsource (BLDR)
656K shares
Lattice Semiconductor (LSCC)
563K → 382K shares (−32%)
Descartes Systems Group (DSGX)
802K → 835K shares (+4%)
Avient (AVNT)
1.57M → 1.55M shares (−1%)
Braze (BRZE)
3.97M → 2.62M shares (−34%)
Fabrinet (FN)
285K → 97K shares (−66%)
Cheniere Energy (LNG)
459K → 228K shares (−50%)
Insulet Corporation (PODD)
1,682 → 353K shares (+20870%)
Roblox (RBLX)
986K shares
Argenx (ARGX)
57K shares
Newamsterdam Pharma Co N.V. (NAMS)
2.2M → 1.54M shares (−30%)
Jabil (JBL)
349K → 135K shares (−61%)
Talen Energy (TLN)
131K → 135K shares (+3%)